Brief by Shorts91 Newsdesk / 03:41pm on 16 May 2024,Thursday Health & Wellness
The Union health ministry faces hurdles in finding pharmaceutical collaborators for a salmonella vaccine development initiative. Reopening calls for expressions of interest twice in three months due to lack of responses, the ministry aims to develop a broad-spectrum vaccine targeting typhoid, paratyphoid fever, and salmonella gastroenteritis. With the rising concern of multidrug-resistant strains, the initiative seeks to address pressing public health issues. Hyderabad-based companies Bharat Biotech and Biological E currently produce some salmonella vaccines in India. The collaboration offers manufacturers an opportunity to contribute to a critical public health initiative.
